Vir Biotechnology VIR
NASDAQ VIR
$13.15 -0.50 (-3.66%)
At close: Nov 10, 2026 · 4:00 PM EST

Vir Biotechnology (VIR) Other Operating Expenses (2019 - 2025)

Updated

Vir Biotechnology's Other Operating Expenses was $80.04 million in Q3 2026, down 47.1% from $151.44 million a year earlier and down 40.8% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Other Operating Expenses (2019 - 2025) Analysis & Trends

On a trailing twelve-month basis, Vir Biotechnology's Other Operating Expenses was $412.59 million through Sep 30, 2026, down 12.9% year-over-year; for FY2025, it was $455.97 million, down 10.0% from FY2024.

  • Other Operating Expenses shows a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
  • In earlier years, Other Operating Expenses was $506.5 million in FY2024 (-12.6%), $579.72 million in FY2023 (+22.1%), $474.65 million in FY2022 (+5.9%) and $448.01 million in FY2021 (+48.1%).
  • The Q3 2026 figure marks the lowest quarterly Other Operating Expenses since Q3 2020.
  • Compared with a year earlier, Other Operating Expenses was higher in two of the last eight quarters, with an average decline of 5.9%.
  • The best year-over-year quarter for Other Operating Expenses over five years was Q1 2023 (growth of 74.7%); the worst was Q3 2026 (a decline of 47.1%).
  • Per Business Quant data, VIR's Other Operating Expenses in the three quarters before Q3 2026 was $135.28 million (Q2 2026), $108.92 million (Q1 2026) and $88.35 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Vir Biotechnology 2.28 Bn 363.84 Mn 188,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 26,000.00
Sep 30, 2025 -11,000.00
Jun 30, 2025 11,000.00
Dec 31, 2024 684,000.00
Sep 30, 2024 50,000.00
Jun 30, 2024 52,000.00
Mar 31, 2024 59,000.00
Dec 31, 2023 798,000.00
Sep 30, 2023 38,000.00
Jun 30, 2023 22,000.00
Mar 31, 2023 1.91 Mn
Dec 31, 2022 6.00 Mn
Sep 30, 2022 22.25 Mn
Jun 30, 2022 27.92 Mn
Mar 31, 2022 90.15 Mn
Dec 31, 2021 56.88 Mn
Sep 30, 2021 7.84 Mn
Jun 30, 2021 1.14 Mn
Jun 30, 2019 1,000.00
API Access

Vir Biotechnology Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=VIR&period=max&api_key=YOUR_API_KEY